Infectious Diseases in Obstetrics and Gynecology (Jan 2003)

Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours for Treatment of Acute Pelvic Infections: A Prospective, Multicenter, Randomized, Double-Blind Study

Subir Roy,
Iliana Higareda,
Edith Angel-Muller,
Mahmoud Ismail,
Caren Hague,
Ben Adeyi,
Gail L. Woods,
Hedy Teppler

Affiliations

Subir Roy: Keck School of Medicine at USC, Los Angeles, CA, USA
Iliana Higareda: Nuevo Hospital Civil, Guadalajara, Mexico
Edith Angel-Muller: Universidad Nacional de Colombia, Bogota, Colombia
Mahmoud Ismail: University of Chicago, Chicago, IL, USA
Caren Hague: Merck Research Laboratories, West Point, PA, USA
Ben Adeyi: Merck Research Laboratories, West Point, PA, USA
Gail L. Woods: Merck Research Laboratories, West Point, PA, USA
Hedy Teppler: Merck Research Laboratories, West Point, PA, USA

DOI: https://doi.org/10.1155/S1064744903000048
Journal volume & issue: Vol. 11, no. 1
pp. 27 – 37

Abstract

Objective: To compare ertapenem therapy with piperacillin–tazobactam therapy for the management of acute pelvic infections.

Published in Infectious Diseases in Obstetrics and Gynecology

ISSN: 1064-7449 (Print); 1098-0997 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/7281

About the journal